Edgewise Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.About EWTX
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
CEOKevin Koch
CEOKevin Koch
Employees110
Employees110
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2017
Founded2017
Employees110
Employees110
EWTX Key Statistics
Market cap1.51B
Market cap1.51B
Price-Earnings ratio-9.24
Price-Earnings ratio-9.24
Dividend yield—
Dividend yield—
Average volume615.03K
Average volume615.03K
High today$14.49
High today$14.49
Low today$13.90
Low today$13.90
Open price$14.14
Open price$14.14
Volume622.65K
Volume622.65K
52 Week high$38.12
52 Week high$38.12
52 Week low$10.60
52 Week low$10.60
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own EWTX. This list is generated using Robinhood data, and it’s not a recommendation.